• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » MassDevice On Call: FDA’s top criminal investigator resigns amidst scrutiny

MassDevice On Call: FDA’s top criminal investigator resigns amidst scrutiny

November 29, 2010 By MassDevice

MassDevice On Call

FDA’s top criminal investigator resigns amidst scrutiny. Terry Vermillion told the Food & Drug Administration that he would step down as head of the agency’s Office of Criminal Investigations, where he served for 18 years, about two months after a whistleblower made allegations about the alteration of internal agency reports and other ethical violations, according to The Wall Street Journal.

Massachusetts allows health insurance rate hikes. After rejecting double-digit increases earlier this year, Massachusetts regulators are allowing a more modest round of rate hikes to take effect in January for health insurance policies covering small businesses and individuals, according to The Boston Globe.

WalkMed issues recall of pole mount infusion pumps.  Englewood, Colo.-based, WalkMed Infusion LLC is conducting a recall for its Triton pole mount infusion pumps. The reason for the recall is that the pump’s door open alarm does not always alert the user that the door is open. “In this state, the pump can still run even though the pump door may be open and could result in a free flow perfusion, and may cause serious injury or death,” according to the FDA.

Republican version of health insurance reform. What if a Republican governor and a Republican legislature implemented their version of health insurance reform for which the federal government would pay? It’s a great idea. A bill has already been introduced in the Senate by Ron Wyden (D-Ore.) and Scott Brown (R-Mass.), writes Health Care Policy and Marketplace Review blog.

Researchers reverse age degeneration in mice. Scientists restored the sense of smell and fertility and reversed brain disease in prematurely aged mice. The achievement could mean treating humans for age-related disorders in just around the corner, reports The Wall Street Journal.

CT scan usage soars. The number of annual emergency room visits that included CT scans increased by 500 percent — from 2.7 million to 16.2 million– between 1995 and 2007, according to a new study in the Nov. 29, issue of Radiology, according to ModernHealthcare.

Now the time to replace long-term care safety net? Medicaid could be on the fiscal chopping block, writes Howard Gleckman, senior research associate at the Urban Institute, in a Kaiser Health News opinion. Now may be the right time to replace the tattered long-term care safety net.

Cleveland Clinic Abu Dhabi part of UAE growth. The United Arab Emirates is on a breakneck growth agenda dubbed Plan Abu Dhabi 2030. The tiny emirate has six hotels opening in 2011 and already hosts three PGA-standard golf courses. But the focus of economic development is on less glamorous projects, like a $5.7 billion aluminum plant, the development of a healthcare center with help from Johns Hopkins University and the Cleveland Clinic, and a host of energy projects, according to eMoneyDaily.

Scott Hamilton bounces back (again). Olympic figure skater Scott Hamilton is bouncing back from surgery at the Cleveland Clinic to remove an aneurysm resulting from benign brain tumor surgery at another institution, according to People magazine. Hamilton, who overcame testicular cancer and a pituitary gland tumor two years ago, lost two-thirds of the vision in his right eye — a risk of the aneurysm surgery.

J&J unit plagued by manufacturing flaws. Months after Johnson & Johnson’s (NYSE:JNJ) McNeil Consumer Healthcare unit recalled millions of bottles of Tylenol and other over-the-counter drugs, the division still is plagued with manufacturing flaws, according to the FDA, The New York Times reports.

Colorectal cancer vaccine starts with tumor. Dartmouth researchers have found that could treat colorectal cancer with a vaccine that uses the patient’s own tumor, according to EmaxHealth blog.

Material from MedCity News was used in this report.

Filed Under: Business/Financial News, News Well Tagged With: FDA Office of Criminal Investigations, Johnson and Johnson

In case you missed it

  • Texas power grid struggles a year after cold stopped semiconductor plants
  • The road to a robot: Medtronic’s development process for Hugo RAS system
  • How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
  • Zimmer Biomet appoints new chief accounting officer
  • Cook Medical makes next-gen in vitro fertilization incubator available in U.S., Canada
  • Boston Scientific co-founder Peter Nicholas is dead at 80
  • How Boston Scientific uses clinical feedback to advance innovation
  • How Stryker includes users for product design in the digital age
  • DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event
  • FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
  • Medtronic completes Intersect ENT acquisition
  • Steris rises on Street-beating Q4, sets fiscal 2023 guidance
  • Medtronic must sell Intersect ENT subsidiary to satisfy FTC concerns
  • Abbott partners with Women as One to help more underrepresented clinicians lead trials
  • Lucira Health asks FDA for EUA on molecular at-home COVID/flu test
  • Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring
  • Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes

RSS From Medical Design & Outsourcing

  • Texas power grid struggles in heat one year after record cold stopped semiconductor plants
    A heat wave in Texas took at least six power plants offline Friday with high temperatures forecasted to blaze throughout this week. A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production. There’s no… […]
  • How Stryker includes users for product design in the digital age
    Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker… […]
  • DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event
    DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event.  The Miami-based mid-stage company beat out 1,000 applicants, more than 20 of which competed on-site May 10–11, 2022 at DeviceTalks Boston. DermaSensor walked away with… […]
  • Steris rises on Street-beating Q4, sets fiscal 2023 guidance
    Steris (NYSE:STE) shares ticked up today on fourth-quarter financial results that came in just ahead of the consensus forecast. The infection prevention technology company — headquartered in Dublin, Ireland, and run operationally out of Mentor, Ohio — posted profits of $52.3 million, or 52¢ per share, on sales of $1.2 billion for the three months… […]
  • Lucira Health asks FDA for EUA on molecular at-home COVID/flu test
    Lucira Health (Nasdaq: LHDX) today said it has asked the FDA for an emergency use authorization (EUA) for its combination COVID-19 and flu test. Emeryville, California–based Lucira said the at-home test would be available with a prescription to test for SARS-CoV-2, Influenza A and Influenza B. The Nucleic Acid Amplification Test (NAAT) platform has a… […]
  • Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring
    AcuityMD said today it has raised $31 million in Series A funding for its medical device commercialization platform. “With our new funding, we plan to double down on R&D by growing our engineering team from 15 to over 40 over the next year,” AcuityMD co-founder and CEO Michael Monovoukas said in a blog post. “We’ll… […]
  • Rockley Photonics announces $81.5M private placement
    Rockley Photonics (NYSE:RKLY) announced today that it entered into agreements for an $81.5 million private placement. Participating investors agreed to purchase $81.5 million in convertible senior secured notes (due 2026) and warrants to purchase 26.5 million Rockley ordinary shares at an exercise price of $5 per share, subject to certain anti-dilution adjustments. Warrants purchased in… […]
  • Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
    The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech. Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo,… […]
  • Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’
    A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, VP of venture capital at Medtronic (NYSE: MDT). He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company. (Read more in his DeviceTalks speaker bio.) Medtronic has more than $500 million in… […]
  • Here’s where Harvard’s engineering dean sees medtech research going
    Surgical robotics, artificial intelligence, and combatting climate change are but some of the priorities that have Harvard’s engineering school dean excited. Speaking today at DeviceTalks Boston, Frank J. Doyle III described the Harvard John A. Paulson School of Engineering and Applied Sciences as a “well-kept secret” historically. But Harvard engineering is staking out a strong position when it… […]
  • gBETA Medtech accelerator picks its next startups
    The gBETA Medtech virtual accelerator today named the five startups that will participate in the spring program leading up to the June 21 showcase day. The five startups for the spring 2022 cohort are: Mother of Fact: This mobile app for moms with babies offers nutrition tracking, preventative monitoring and daily coaching from licensed dietitians… […]

Primary Sidebar

DeviceTalks Weekly

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS